Ebola outbreak: Liberia shuts most border points

[Divernan]

7. Excellent questions which need to be thoroughly researched.

I also wonder whether Big Pharma is investing any of its huge profits into researching vaccines or treatments for Ebola. The reason Big Pharma gives to justify huge markups is that, you know, they have to invest so much into research. What I've observed is that the research goes into treatments, not cures or vaccines, because they want lifelong customers. Big Pharma is notorious for avoiding diseases, like malaria, which are typically found in third world countries because there's no profit to be had. With global warming and the movement of tropical diseases up into North America, we need some hefty government grants to university research facilities.

In googling Ebola/immunity, I did find this one article from 2010:
Ebola Survivors In Gulu Undergo Tests for Immunity ...

http://ugandaradionetwork.com/a/story.php?s=28420

Survivors of the deadly Ebola virus that struck Gulu in 2000, are undergoing medical tests to establish their level of immunity.

The tests are part of the measures intended to provide clues on how control future outbreaks of the disease.

An official on the team from the Virus Research Institute, says the tests would ascertain the level of anti-bodies that the survivors have maintained since they recovered from the disease. He says that the results of the tests would help them to determine the method of response should another outbreak occur in future.

In October 2000, Ebola broke out in Gulu and killed about 173 people among the over 400 who got infected.